Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Cyclopentanecarbonyl chloride → 2-oxo-3-tert-butoxycarbonylamino-5-cyclopentylcarbonyl-8-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Cyclopentanecarbonyl chloride | HCID 78284 | — |
| 반응물 | HCID 15490831 | HCID 15490831 | — |
| 반응물 | 2-oxo-3-tert-butoxycarbonylamino-8-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine | HCID 21201581 | — |
| 생성물 | 2-oxo-3-tert-butoxycarbonylamino-5-cyclopentylcarbonyl-8-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine | HCID 21201645 | — |
반응 단계
Step 1 of Example 1 was repeated except that cyclopentylcarbonyl chloride was used instead of pivaloyl chloride, and that 2-oxo-3-tert-butoxycarbonylamino-8-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine obtained from Referential Example 4 was used instead of 2-oxo-3-tert-butoxycarbonylamino-1,3,4,5-tetrahydro-2H-1,5-benzodiazepine, to thereby obtain the title compound.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US06239131B1 |
| 출처 데이터셋 | uspto-grants-2001_05 |
| ORD ID | ord-2e9220b093cb4c93864b1382bb275986 |
| 출처 메모 | uspto-grants-2001_05 |